IMC Chicago
BHVN icon

IMC Chicago’s Biohaven BHVN Stock Holding History

IMC Chicago’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$187K Sell
22,080
-27,255
-55% -$298K ﹤0.01% 5058
2025
Q4 		$557K Buy
+49,335
New +$611K ﹤0.01% 3407

Other funds holding BHVN

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $173M AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

IMC Chicago's BHVN Position: Q1 2026 in Review

IMC Chicago reduced its Biohaven (BHVN) stake by 55% in Q1 2026, selling an estimated $298K and leaving 22,080 shares worth $187K. The position accounts for ﹤0.01% of the portfolio, ranked #5058.

IMC Chicago first reported a position in BHVN in Q4 2025 and has held it in 2 quarters since. The position peaked at $557K in Q4 2025. 275 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

  • IMC Chicago held 22,080 shares of Biohaven worth $187K as of Q1 2026.
  • IMC Chicago sold 27,255 Biohaven shares in Q1 2026, an estimated $298K.
  • Biohaven made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #5058 holding.
  • IMC Chicago first reported a position in Biohaven in Q4 2025 and has held it in 2 quarters since.
  • IMC Chicago's Biohaven position peaked at $557K in Q4 2025.
  • 275 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.